SOX Chemotherapy Clinical Trials
5 recruitingDrug
Phase 25Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital49 enrolled1 locationNCT07353684
Recruiting
Phase 2
Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
GC/GEJC
The First Affiliated Hospital with Nanjing Medical University124 enrolled1 locationNCT07474324
Recruiting
Phase 2
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Gastroesophageal-junction CancerMetastatic Gastric CancerAdvanced Gastric Cancer+1 more
Beijing Friendship Hospital32 enrolled1 locationNCT07315854
Recruiting
Phase 2
A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University460 enrolled1 locationNCT07263386
Recruiting
Phase 1Phase 2
Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
ChemotherapyGastroesophageal Junction AdenocarcinomaImmunotherapy+1 more
West China Hospital88 enrolled4 locationsNCT07072351